News
TRUFF
0.024
+11.06%
0.002
Weekly Report: what happened at TRUFF last week (0622-0626)?
Weekly Report · 6d ago
Weekly Report: what happened at TRUFF last week (0615-0619)?
Weekly Report · 06/22 09:29
Red Light Holland reports positive preclinical mouse study for coca extract to prevent post-GLP-1 weight regain
PUBT · 06/18 13:17
Red Light Holland Reports Positive Preclinical Study Results for Coca in Weight Gain Prevention Post GLP-1 from Magdalena Biosciences, the Joint Venture Held Through Its Wholly Owned Subsidiary, Filament Health
Newsfile · 06/18 13:01
Weekly Report: what happened at TRUFF last week (0608-0612)?
Weekly Report · 06/15 09:29
Red Light Holland signs deal to supply Filament psilocybin candidate PEX010 for UCSF trial
PUBT · 06/08 15:35
Red Light Holland's Wholly Owned Subsidiary, Filament Health, Signs Agreement to Supply PEX010 Botanical Psilocybin Drug Candidate for Study at GHU Paris Psychiatrie & Neurosciences in France
Newsfile · 06/08 11:30
Weekly Report: what happened at TRUFF last week (0601-0605)?
Weekly Report · 06/08 09:28
Red Light Holland Announces Filament Health's PEX010 Drug Candidate, the Standardized and Patented Natural Psilocybin Trusted Across 80+ Studies Globally, Selected by UCSF for Study Probing Preclinical Alzheimer's Markers
Newsfile · 06/04 11:30
Weekly Report: what happened at TRUFF last week (0525-0529)?
Weekly Report · 06/01 09:29
Red Light Holland expands New Zealand supply partnership with Allu Therapeutics for Filament psilocybin candidate PEX010
PUBT · 05/29 17:20
Red Light Holland expands New Zealand supply partnership with Allu Therapeutics to include Filament psilocybin candidate PEX010
PUBT · 05/25 12:40
Red Light Holland Expands New Zealand Partnership with Allu Therapeutics to Advance Access to Filament Health's GMP-Compliant PEX010 Botanical Psilocybin Drug Candidate
Newsfile · 05/25 12:40
Weekly Report: what happened at TRUFF last week (0518-0522)?
Weekly Report · 05/25 09:31
Weekly Report: what happened at TRUFF last week (0511-0515)?
Weekly Report · 05/18 09:31
Red Light Holland shareholders approve proposed corporate name change at annual meeting
PUBT · 05/15 16:59
Red Light Holland supplies PEX010 for UBC bipolar II depression psilocybin trial
PUBT · 05/15 16:57
Red Light Holland's Wholly Owned Subsidiary, Filament Health, Advances PEX010 Clinical Footprint with New Canadian Academic Studies in Palliative Care, Bipolar II Depression, and Healthy Adult Mechanism Research
Newsfile · 05/14 12:30
Red Light Holland CFO Keith Li to resign after annual audit completion
PUBT · 05/13 13:28
Red Light Holland shareholders approve proposed corporate name change at annual meeting
PUBT · 05/13 13:13
More
Webull provides a variety of real-time TRUFF stock news. You can receive the latest news about Red Light Hollan through multiple platforms. This information may help you make smarter investment decisions.
About TRUFF
Red Light Holland Corp. is a Canada-based company, advancing a focused strategy within the legal psychedelic sector, centered on consensual data collection and research & development initiatives designed to expand naturally occurring drug development, understanding of psilocybin use and consumer experiences. The Company also operates commercial activities across Europe and North America, including psilocybin truffle sales in the Netherlands' legal market and mushroom home grow kits offered through business-to-business (B2B) and direct-to-consumer (DTC) channels, in compliance with applicable laws. Its product line consists of the iMicrodose kit, Maka Magic Truffles, Home Grow Mushroom Kits, MisterCap, and Wisdom Truffle, among others. Its subsidiaries include RLH Netherlands B.V., RLH Farms B.V., SR Wholesale B.V., MiniChamp B.V., Radix Motion Inc. and others. The Company also has a portfolio of approximately 76 issued patents across 15 patent families and its drug candidate, PEX010.